BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 15978949)

  • 1. Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
    Strupp C; Fenk R; Kündgen A; Gattermann N; Haas R; Germing U
    Leuk Res; 2005 Aug; 29(8):967-9. PubMed ID: 15978949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
    Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
    Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
    Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
    Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
    Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Dedic K; Zák P
    Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hairy cell leukemia successfully treated with deoxycoformycin].
    Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
    Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of hairy cell leukemia in a patient with antiphospholipid syndrome.
    Diz-Kucukkaya R; Dincol G; Kamali S; Kural F; Inanc M
    Lupus; 2007; 16(4):286-8. PubMed ID: 17439936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P; Chrobák L; Dĕdic K; Podzimek K
    Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of hairy cell leukemia with pentostatin].
    Fujita H; Koharazawa H; Nishida H; Terada S; Morishita T; Kuroyama Y; Ohata M; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
    Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy cell leukaemia with advanced treatment - a case report.
    Momen A; Sarker CB; Siddiqui NI; Huq MH; Jamal MF; Talukder SI; Rahman KM
    Mymensingh Med J; 2003 Jul; 12(2):134-7. PubMed ID: 12894049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of myeloid metaplasia with myelofibrosis and hairy-cell leukemia.
    Subramanian VP; Gomez GA; Han T; Kim U; Minowada J; Sandberg A
    Arch Intern Med; 1985 Jan; 145(1):164-6. PubMed ID: 3970633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide for the treatment of idiopathic myelofibrosis.
    Strupp C; Germing U; Scherer A; Kündgen A; Mödder U; Gattermann N; Haas R
    Eur J Haematol; 2004 Jan; 72(1):52-7. PubMed ID: 14962263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
    Cornfield DB; Mitchell Nelson DM; Rimsza LM; Moller-Patti D; Braylan RC
    Am J Hematol; 2001 Aug; 67(4):223-6. PubMed ID: 11443633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairy-cell leukemia: a rare blood disorder in Asia.
    Josephine FP; Nissapatorn V
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():190-4. PubMed ID: 17547079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
    Habberstad AH; Tran HTT; Randen U; Spetalen S; Dybedal I; Tjønnfjord GE; Dahm AEA
    J Med Case Rep; 2018 Apr; 12(1):105. PubMed ID: 29685167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [European-American-type hairy cell leukemia without splenomegaly, treated successfully with deoxycoformycin].
    Muta T; Okamura T; Oshima K; Kikuchi M; Niho Y
    Rinsho Ketsueki; 2001 May; 42(5):426-31. PubMed ID: 11452464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.